RECBIO-B
021795.0300.00% ( 0.000 )
RECBIO-B (02179)
Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic...
- Open
- 5.030
- High
- 5.030
- Low
- 5.030
- Prev. Close
- 5.030
- Volume
- 5.00K
- Turnover
- 25.15K
- Avg Price
- 5.030
- Bid/Ask Ratio
- -100.00%
- Amplitude
- 0.00%
- 52wk High
- 8.080
- Volume Ratio
- 3.59
- Turnover Ratio
- 0.00%
RECBIO-B Analyst Rating
View MoreForecast & Rating
Apr 17, 2025Price forecast
HK$12.99158.20%
Forecast & Rating-
0analysts
News
- PUBT · Jul 31 at 04:21 AM
Recbio expects H1 loss to narrow to RMB 201.23-222.41 million
- Tip Ranks · Jul 23 at 05:40 AM
Recbio Reports Shingles Vaccine Milestone and Delay in HPV Filing
- PUBT · Jul 23 at 05:25 AM
Jiangsu Recbio says NMPA accepts filing for REC610 shingles vaccine approval
- PUBT · Jul 21 at 05:00 AM
Beijing Ubox Online files HKEX next-day disclosure return on share repurchase for cancellation
- AASTOCKS · Feb 1 at 08:57 PM
RECBIO H shares full circulation has been filed with the China Securities Regulatory Commission, involving a conversion of 24% equity in H shares
- Tip Ranks · Jan 30 at 09:09 AM
Recbio Gains CSRC Green Light for Full Circulation of 142 Million Domestic Shares as H Shares
